Latest Options Offer News

Sabre Resources (ASX:SBR) has lodged a prospectus offering up to 530 million new options, aiming to clear trading restrictions and raise capital for exploration and acquisitions.

Somerset Minerals (ASX:SMM) has kicked off a $3.17 million capital raise combining a $2 million placement and a $1.17 million entitlement offer, aiming to advance exploration at its Coppermine copper project in Nunavut, Canada. The offer includes attaching options and management incentives, with participation restricted to shareholders in select jurisdictions.

ClearVue Technologies is inviting eligible shareholders to participate in a $1 million Share Purchase Plan at a discount, following a $5 million institutional placement. The capital raised will support ERP rollout, R&D, and working capital.

1414 Degrees offers bonus Loyalty Options to shareholders alongside a $8.45 million capital raise aimed at advancing its clean energy projects, including the Aurora Energy Precinct and SiNTL commercialisation.

Centuria Capital Group has launched the retail component of its $100 million entitlement offer, aiming to raise approximately $35 million. The equity raising supports expansion in AI infrastructure and real estate funds management.

Australian Oil Company Limited has closed its Share Purchase Plan, raising $155,000 by issuing over 54 million shares at $0.0029 each, to support ongoing exploration in Queensland’s Surat Basin.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

Buru Energy has launched a prospectus offering over 207 million new options free-attaching to a recent $5.3 million placement, aiming to back the commercialisation of its Rafael Gas Project and bolster working capital.

Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.

Thrive Tribe Technologies (ASX:1TT) is issuing up to 1.5 billion free attaching options to recent placement participants, exercisable at $0.003 and expiring in 2029, potentially raising $4.5 million if fully exercised.

Bounty Oil & Gas NL has issued a prospectus offering over 632 million new options to eligible investors as part of a broader recapitalisation, potentially raising $6.3 million if exercised.

Racura Oncology has secured $31.2 million in funding to advance its lead cancer drug RC220, including a strategic $1 million private placement to a specialist healthcare investor.